금융 뉴스 허브

Nasdaq Drops as Market Bets Against AI Ahead of Nvidia Earnings

Technology stocks tumbled again on Monday because Wall Street is worried about artificial intelligence shares ahead of another key earnings test. The Nasdaq Composite fell 0.8%. The Dow, which lacks ...

Update: US Equity Indexes Mixed as Chipmakers Hit Technology, Bessent Unveils Plans to Choke Iran

(Updates with index/price moves and geopolitical news from the first paragraph.) US equity indexe

Visa Surges 2.4% as Payment Stocks Seize Market Leadership

Investors are favoring fee-driven networks while Nvidia anxiety punishes capital-intensive technology companies.

Amazon develops 'Tetromino' as it steps up warehouse automation

South Korean Won: Consolidation zone eyed against US Dollar – Commerzbank

Commerzbank’s Charlie Lay and Dr. Henry Hao highlight South Korea’s strong export-led growth and large current-account surplus as key drivers of Korean Won strength against the Dollar.

Amazon Jumps 1.8% as AWS Growth Overpowers Tech Anxiety

Investors are rewarding visible cloud returns while heavily financed AI infrastructure stocks come under pressure.

US Dollar Index: Cautious rebound capped near 100 – Scotiabank

Scotiabank strategists Shaun Osborne and Eric Theoret observe that the US Dollar (USD) is modestly stronger as markets start the week cautiously, with equities defensive and Treasuries firmer.

Chinese Yuan: Gradual appreciation bias with key levels against US Dollar – OCBC

OCBC’s Sim Moh Siong and Christopher Wong highlight that RMB and CNH remain supported by softer USD dynamics and exporter conversion, but the People’s Bank of China is signalling a preference for grad ...

FS Bancorp announces up to $5M stock buyback program

Analysts See Drastic Change For This Particular Part Of Healthcare

The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for the industry. While Moderna shares have remai ...

EZCORP climbs 7%, adding to previous day's rally

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.